RecruitingNCT05659160

Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2

Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2 (TRACK-LVO-2): an Imaging-based Patient Registry Study


Sponsor

Tianjin Huanhu Hospital

Enrollment

5,000 participants

Start Date

Nov 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to create a comprehensive, real-world, multi-center observational registry of consecutive patients admitted to hospitals with acute ischemic stroke (AIS) caused by large vessel occlusions (LVO), who are treated with either endovascular therapy (EVT) or the best available medical management (BMM).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tracks and analyzes outcomes for patients who have had an acute ischemic stroke caused by a large vessel blockage in the brain (large vessel occlusion, or LVO). Researchers want to understand which treatment approaches — catheter-based clot removal (endovascular therapy) or medication alone — lead to the best recovery, and how patients are triaged and treated at different types of hospitals. You may be eligible if: - You are 18 or older - You had an ischemic stroke confirmed by CT or MRI scan - A large vessel blockage was confirmed in your brain (by CT angiography or MR angiography) - You were admitted between January 2018 and January 2028 - You received endovascular therapy (clot retrieval) or medical management You may NOT be eligible if: - There are no exclusion criteria for this study — if you meet the above criteria, you may be included Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndovascular Therapy

Endovascular therapy, as an adjunct to standard stroke therapy, may be beneficial for a very select population of patients who present with an acute ischemic stroke and have a proven large, proximal occlusion on imaging. Endovascular therapy includes any one or more of the following: Intra-arterial thrombolytic therapy, aspiration, stent retrieval, or a combination of multiple mechanical devices.


Locations(4)

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, China

The Sencond Hospital of Tianjin Medical University

Tianjin, Tianjin Municipality, China

Tianjin Huanhu Hospital

Tianjin, Tianjin Municipality, China

Beijing University Binhai Hospital

Tianjin, Tianjin Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05659160


Related Trials